Seizert Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.3M | Sell |
729,793
-28,324
| -4% | -$1.65M | 2.04% | 20 |
|
|
2025
Q4 | $40.9M | Buy |
758,117
+38,725
| +5% | +$1.86M | 1.73% | 27 |
|
|
2025
Q3 | $32.4M | Buy |
719,392
+6,604
| +0.9% | +$308K | 1.41% | 32 |
|
|
2025
Q2 | $33M | Buy |
712,788
+9,167
| +1% | +$450K | 1.45% | 34 |
|
|
2025
Q1 | $42.9M | Sell |
703,621
-1,114
| -0.2% | -$64.9K | 1.97% | 21 |
|
|
2024
Q4 | $39.9M | Sell |
704,735
-12,519
| -2% | -$699K | 1.8% | 24 |
|
|
2024
Q3 | $37.1M | Buy |
717,254
+109,849
| +18% | +$5.15M | 1.68% | 25 |
|
|
2024
Q2 | $25.2M | Sell |
607,405
-35,528
| -6% | -$1.59M | 1.25% | 33 |
|
|
2024
Q1 | $34.9M | Buy |
642,933
+141,533
| +28% | +$7.21M | 1.61% | 28 |
|
|
2023
Q4 | $25.7M | Sell |
501,400
-19,102
| -4% | -$1M | 1.3% | 34 |
|
|
2023
Q3 | $30.2M | Buy |
520,502
+8,462
| +2% | +$518K | 1.6% | 26 |
|
|
2023
Q2 | $32.7M | Buy |
512,040
+78,308
| +18% | +$5.25M | 1.76% | 23 |
|
|
2023
Q1 | $30.1M | Buy |
433,732
+34,458
| +9% | +$2.43M | 1.65% | 24 |
|
|
2022
Q4 | $28.7M | Sell |
399,274
-23,688
| -6% | -$1.79M | 1.53% | 24 |
|
|
2022
Q3 | $30.1M | Buy |
422,962
+950
| +0.2% | +$68.9K | 1.7% | 23 |
|
|
2022
Q2 | $32.5M | Sell |
422,012
-9,363
| -2% | -$713K | 1.72% | 22 |
|
|
2022
Q1 | $31.5M | Sell |
431,375
-4,664
| -1% | -$313K | 1.45% | 29 |
|
|
2021
Q4 | $27.2M | Buy |
436,039
+364,645
| +511% | +$21.4M | 1.22% | 34 |
|
|
2021
Q3 | $4.22M | Buy |
71,394
+35,240
| +97% | +$2.32M | 0.19% | 81 |
|
|
2021
Q2 | $2.42M | Buy |
36,154
+1,579
| +5% | +$103K | 0.12% | 108 |
|
|
2021
Q1 | $2.18M | Sell |
34,575
-13,528
| -28% | -$842K | 0.11% | 111 |
|
|
2020
Q4 | $2.98M | Buy |
48,103
+1,483
| +3% | +$91.2K | 0.17% | 70 |
|
|
2020
Q3 | $2.81M | Buy |
46,620
+9,444
| +25% | +$568K | 0.18% | 68 |
|
|
2020
Q2 | $2.19M | Buy |
37,176
+20,442
| +122% | +$1.22M | 0.15% | 71 |
|
|
2020
Q1 | $933K | Sell |
16,734
-13,752
| -45% | -$841K | 0.07% | 109 |
|
|
2019
Q4 | $1.96M | Buy |
30,486
+24,312
| +394% | +$1.39M | 0.1% | 93 |
|
|
2019
Q3 | $313K | Buy |
6,174
+105
| +2% | +$4.93K | 0.02% | 176 |
|
|
2019
Q2 | $275K | Hold |
6,069
| – | – | 0.01% | 188 |
|
|
2019
Q1 | $290K | Hold |
6,069
| – | – | 0.01% | 197 |
|
|
2018
Q4 | $315K | Buy |
6,069
+224
| +4% | +$12K | 0.01% | 180 |
|
|
2018
Q3 | $363K | Hold |
5,845
| – | – | 0.01% | 177 |
|
|
2018
Q2 | $370K | Hold |
5,845
| – | – | 0.01% | 181 |
|
|
2018
Q1 | $370K | Hold |
5,845
| – | – | 0.01% | 181 |
|
|
2017
Q4 | $358K | Buy |
5,845
+1,000
| +21% | +$62.5K | 0.01% | 166 |
|
|
2017
Q3 | $309K | Sell |
4,845
-4,000
| -45% | -$234K | 0.01% | 162 |
|
|
2017
Q2 | $493K | Sell |
8,845
-860
| -9% | -$46.8K | 0.02% | 157 |
|
|
2017
Q1 | $528K | Hold |
9,705
| – | – | 0.02% | 161 |
|
|
2016
Q4 | $567K | Sell |
9,705
-24,884
| -72% | -$1.36M | 0.02% | 162 |
|
|
2016
Q3 | $1.86M | Sell |
34,589
-1,485
| -4% | -$95.4K | 0.07% | 119 |
|
|
2016
Q2 | $2.65M | Hold |
36,074
| – | – | 0.1% | 108 |
|
|
2016
Q1 | $2.3M | Sell |
36,074
-90
| -0.2% | -$5.68K | 0.08% | 124 |
|
|
2015
Q4 | $2.49M | Hold |
36,164
| – | – | 0.08% | 131 |
|
|
2015
Q3 | $2.14M | Sell |
36,164
-539
| -1% | -$34.2K | 0.06% | 132 |
|
|
2015
Q2 | $2.44M | Hold |
36,703
| – | – | 0.06% | 134 |
|
|
2015
Q1 | $2.37M | Sell |
36,703
-1,140
| -3% | -$71.4K | 0.06% | 136 |
|
|
2014
Q4 | $2.23M | Sell |
37,843
-3,803
| -9% | -$214K | 0.05% | 142 |
|
|
2014
Q3 | $2.13M | Sell |
41,646
-885
| -2% | -$44.2K | 0.04% | 135 |
|
|
2014
Q2 | $2.06M | Hold |
42,531
| – | – | 0.04% | 137 |
|
|
2014
Q1 | $2.21M | Sell |
42,531
-357
| -0.8% | -$19K | 0.05% | 85 |
|
|
2013
Q4 | $2.28M | Sell |
42,888
-1,035
| -2% | -$52.7K | 0.05% | 78 |
|
|
2013
Q3 | $2.03M | Sell |
43,923
-21,308
| -33% | -$935K | 0.06% | 78 |
|
|
2013
Q2 | $2.92M | Buy |
+65,231
| New | +$2.83M | 0.08% | 71 |
|
Other funds holding BMY
VCM
VPM
Seizert Capital Partners's BMY Position: Q1 2026 in Review
Seizert Capital Partners reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q1 2026, selling an estimated $1.65M and leaving 729,793 shares worth $44.3M. The position accounts for 2.04% of the portfolio, ranked #20.
Seizert Capital Partners first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Seizert Capital Partners held 729,793 shares of Bristol-Myers Squibb worth $44.3M as of Q1 2026.
- Seizert Capital Partners sold 28,324 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.65M.
- Bristol-Myers Squibb made up 2.04% of Seizert Capital Partners's portfolio in Q1 2026, its #20 holding.
- Seizert Capital Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.